Fatemah continues treatment with interferon injections (a chemotherapy-type treatment), and Columbus Childrens Hospital physicians are satisfied with her progress. She has not experienced any infections and has been breathing, eating and playing normally. At this point in time plans remain to treat Fatemah without surgery--treatment for a large hemangioma such as hers is a slow and deliberate process and is not a medical condition that allows a statement of a definite treatment end date.
About Nationwide Children's Hospital
Named to the Top 10 Honor Roll on U.S. News & World Report’s 2017-18 list of “America’s Best Children’s Hospitals,” Nationwide Children’s Hospital is one of America’s largest not-for-profit freestanding pediatric healthcare systems providing wellness, preventive, diagnostic, treatment and rehabilitative care for infants, children and adolescents, as well as adult patients with congenital disease. Nationwide Children’s has a staff of nearly 13,000 providing state-of-the-art pediatric care during more than 1.4 million patient visits annually. As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Children’s physicians train the next generation of pediatricians and pediatric specialists. The Research Institute at Nationwide Children’s Hospital is one of the Top 10 National Institutes of Health-funded freestanding pediatric research facilities. More information is available at NationwideChildrens.org.